liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Personalized Approach to Growth Hormone Treatment: Clinical Use of Growth Prediction Models
Leiden University, Netherlands .
University of Tubingen, Germany .
University of Gothenburg, Sweden .
Autonomous University of Barcelona, Spain .
Show others and affiliations
2013 (English)In: Hormone Research in Paediatrics, ISSN 1663-2818, Vol. 79, no 5, 257-270 p.Article, review/survey (Refereed) Published
Abstract [en]

The goal of growth hormone (GH) treatment in a short child is to attain a fast catch-up growth toward the target height (TH) standard deviation score (SDS), followed by a maintenance phase, a proper pubertal height gain, and an adult height close to TH. The short-term response variable of GH treatment, first-year height velocity (HV) (cm/year or change in height SDS), can either be compared with GH response charts for diagnosis, age and gender, or with predicted HV based on prediction models. Three types of prediction models have been described: the Kabi International Growth Hormone Study models, the Gothenburg models and the Cologne model. With these models, 50-80% of the variance could be explained. When used prospectively, individualized dosing reduces the variation in growth response in comparison with a fixed dose per body weight. Insulin-like growth factor-I-based dose titration also led to a decrease in the variation. It is uncertain whether adding biochemical, genetic or proteomic markers may improve the accuracy of the prediction. Prediction models may lead to a more evidence-based approach to determine the GH dose regimen and may reduce the drug costs for GH treatment. There is a need for user-friendly software programs to make prediction models easily available in the clinic.

Place, publisher, year, edition, pages
Karger , 2013. Vol. 79, no 5, 257-270 p.
Keyword [en]
Growth hormone deficiency, Idiopathic short stature, Small for gestational age, Insulin-like growth factor I, Growth hormone receptor
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-99414DOI: 10.1159/000351025ISI: 000324541500001OAI: diva2:656881

Funding Agencies|Pfizer||

Available from: 2013-10-17 Created: 2013-10-17 Last updated: 2013-10-17

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Bang, Peter
By organisation
Division of Clinical SciencesFaculty of Health Sciences
In the same journal
Hormone Research in Paediatrics
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 35 hits
ReferencesLink to record
Permanent link

Direct link